FIRST IN THE BALTICS: NORTHWAY BIOTECH OPENS €61 MILLION CELL THERAPY AND PERSONALIZED MEDICINE CDMO IN VILNIUS
Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines and first customer programs already secured. The first…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- RESULTS OF PLACING OF SHARES IN INTEA FASTIGHETER AB (PUBL)
- Nidhogg Resources informs about the Administrative Court of Appeal's rejection of the exploration permits Vintjärn and Kölen no. 6
- Irisity further extends existing credit facility with largest shareholder
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →